Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression

Nature Medicine

Volumn 17, Issue 1, 2011, Pages 123-129

  Bhang, Hyo Eun C ^a   Gabrielson, Kathleen L ^a   Laterra, John ^a,b   Fisher, Paul B ^c   Pomper, Martin G ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIALURIDINE I 125; FLUORODEOXYGLUCOSE; PLASMID DNA; RADIOISOTOPE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BREAST CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HERPES SIMPLEX VIRUS 1; ISOTOPE LABELING; MELANOMA; METASTASIS; MOLECULAR IMAGING; MOUSE; NONHUMAN; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE ELEVATED GENE 3; PROMOTER REGION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR GROWTH;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; MELANOMA; MICE; MOLECULAR BIOLOGY; MOLECULAR IMAGING; NEOPLASM METASTASIS; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS;

RODENTIA;

EID: 78651240824     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2269     Document Type: Article

References (38)

1. Blasberg, R.G. & Tjuvajev, J.G. Molecular-genetic imaging: current and future perspectives. J. Clin. Invest. 111, 1620-1629 (2003).
2. Zhang, Y. et al. ABCG2/BCRP expression modulates d-luciferin based bioluminescence imaging. Cancer Res. 67, 9389-9397 (2007).
3. Uhrbom, L., Nerio, E. & Holland, E.C. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nat. Med. 10, 1257-1260 (2004).
4. Kishimoto, H. et al. In vivo imaging of lymph node metastasis with telomerasespecific replication-selective adenovirus. Nat. Med. 12, 1213-1219 (2006).
5. Padmanabhan, P. et al. Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct. J. Nucl. Med. 47, 270-277 (2006).
6. Freytag, S.O. et al. Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer. Mol. Ther. 15, 1016-1023 (2007).
7. Yaghoubi, S.S. et al. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat. Clin. Pract. Oncol. 6, 53-58 (2009).
8. Su, Z.Z., Shi, Y. & Fisher, P.B. Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene. Proc. Natl. Acad. Sci. USA 94, 9125-9130 (1997).
9. Su, Z.Z. et al. Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter. Proc. Natl. Acad. Sci. USA 102, 1059-1064 (2005).
10. Sarkar, D. et al. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus. Cancer Res. 67, 5434-5442 (2007).
11. Sarkar, D. et al. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice. Cancer Res. 65, 9056-9063 (2005).
12. Sarkar, D. et al. A cancer terminator virus eradicates both primary and distant human melanomas. Cancer Gene Ther. 15, 293-302 (2008).
13. Su, Z., Shi, Y. & Fisher, P.B. Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells. Oncogene 19, 3411-3421 (2000).
14. Sarkar, D. et al. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc. Natl. Acad. Sci. USA 102, 14034-14039 (2005).
15. Wood, M. et al. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther. 6, 367-372 (1999).
16. Peng, K.W. et al. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 8, 1456-1463 (2001).
17. Evans, K.D., Tulloss, T.A. & Hall, N. 18FDG uptake in brown fat: potential for false positives. Radiol. Technol. 78, 361-366 (2007).
18. Shreve, P.D., Anzai, Y. & Wahl, R.L. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 19, 61-77, quiz 150-151 (1999).
19. Ray, S. et al. Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy. Mol. Ther. 16, 1848-1856 (2008).
20. Qiao, J. et al. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther. 9, 168-175 (2002).
21. Iyer, M. et al. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc. Natl. Acad. Sci. USA 98, 14595-14600 (2001).
22. Sadowski, I., Ma, J., Triezenberg, S. & Ptashne, M. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564 (1988).
23. Burton, J.B. et al. Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nat. Med. 14, 882-888 (2008).
24. Iyer, M. et al. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol. Ther. 10, 545-552 (2004).
25. Huyn, S.T. et al. A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis. Clin. Cancer Res. 15, 3126-3134 (2009).
26. Jacobs, A. et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358, 727-729 (2001).
27. Immonen, A. et al. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol. Ther. 10, 967-972 (2004).
28. Klatzmann, D. et al. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum. Gene Ther. 9, 2595-2604 (1998).
29. Trask, T.W. et al. Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol. Ther. 1, 195-203 (2000).
30. Bonnet, M.E., Erbacher, P. & Bolcato-Bellemin, A.L. Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response. Pharm. Res. 25, 2972-2982 (2008).
31. Coelho-Castelo, A.A. et al. Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery. Genet. Vaccines Ther. 4, 1 (2006).
32. Kang, K.K. et al. Safety evaluation of GX-12, a new HIV therapeutic vaccine: investigation of integration into the host genome and expression in the reproductive organs. Intervirology 46, 270-276 (2003).
33. Manam, S. et al. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 43, 273-281 (2000).
34. Ramirez, K. et al. Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen. Hum. Gene Ther. 19, 522-531 (2008).
35. Dwyer, R.M., Bergert, E.R., O'Connor, M.K., Gendler, S.J. & Morris, J.C. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Clin. Cancer Res. 11, 1483-1489 (2005).
36. Tsuruta, Y. et al. A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer. Clin. Cancer Res. 14, 3582-3588 (2008).
37. Su, Z.Z. et al. Potential molecular mechanism for rodent tumorigenesis: mutational generation of Progression Elevated Gene-3 (PEG-3). Oncogene 24, 2247-2255 (2005).
38. Loening, A.M. & Gambhir, S.S. AMIDE: a free software tool for multimodality medical image analysis. Mol. Imaging 2, 131-137 (2003).